Introduction
Hematopoiesis must be durable and¯exible throughout the lifespan of an animal. Durability requires a population of stem cells, which continually renew the diverse pool of progeny in proportions appropriate to their eector functions. Flexibility requires a pool of multipotent progenitor cells capable of spectacular proliferation under the spell of siren cytokines. Mature cells may be deaf to the proliferative signals of these cytokines yet respond to them with increased eector activity. It is likely that the diverse replicative status of dierent cellular subsets in the marrow is sustained in part by intrinsic levels of cell cycle regulators, and in part by modulation of certain of those regulators by environmental cues including cytokines and integrins. Drawing from this thesis, this review focuses on current research that illuminates the following questions: What cell cycle regulators primarily control stem cell quiescence, progenitor replication and cell cycle exit upon dierentiation? How does the circuitry that controls the cell cycle intersect with dierentiation machinery?
Cell cycle machinery
The G1-S cell cycle stage represents a critical period for cells to commit to growth arrest or proliferation. It is during this stage that cells are responsive to cytokines. Once cells are committed to enter S phase, additional stimulation by growth factors is super¯uous (Sherr, 1994) . The following discussion therefore concentrates on molecular regulators of the G0/G1-S phase transition, with a particular emphasis on the regulatory proteins p21/WAF1/CIP1 (p21) and p27Kip1 (p27) that have been widely studied in hematopoietic models.
Both positive and negative regulators guide the progression of cells into and through G1 phase ( Figure 1 ). Distinct Rb-family-E2F repressor complexes prevent progression at dierent cell cycle stages ± E2F/p130 sustains cells in G0 phase (Grana et al., 1998; Vairo et al., 1995) , whereas a Rb-E2F1 complex suppresses the transcription of genes required for progression through G1 phase phase (reviewed in Mayol and Grana, 1997) . As cells proceed from G0 to S phase, cyclin/cyclindependent kinase (cdk) complexes are sequentially activated (Dimri et al., 1996) . Cell cycling is promoted by inactivation of the Rb-E2F1 complex early in G1 by D-cyclin/cdk-4 or -6 complexes or, later in G1, by cyclin E-cdk2 complexes. Cyclin D activity is mitogen-dependent, whereas cyclin E activity is mitogen-independent. In hematopoietic cells, the predominant D cyclins are D2 and D3. Cyclin-cdk activity leads to Rb phosphorylation and dissociation of Rb and E2F-1, which can lead to activation of genes coding for proteins required for S phase. The activity of cyclin-cdk's is opposed by cdk-inhibitors (cdki's) of the INK4a class (p15, 16, 18, 19 ± inhibitors of cdk4 and 6) or the KIP/CIP family (p21, p27 and p57) which are able to inhibit cyclins and cdks of multiple types but have greatest inhibitory activity against cdk2 complexes. The antiproliferative activity of INK4 inhibitors is due in part to their selective binding to cdk4 and cdk6 complexes and prevention of p21 and p27 sequestration by those complexes. This results in greater p21 and p27 binding to cdk2, with resultant growth arrest.
The cell cycle status of hematopoietic stem cells
An appreciation of the role of cell cycle regulators in hematopoiesis must consider the cell cycle status of various hematopoietic cell subsets. Regulated expansion of a small stem cell subset is necessary both to sustain a steady state level of mature blood cells and to upregulate production in response to stresses such as infection or blood loss. These requirements demand either a stem cell pool capable of constant cycling without a loss of pluripotency or a larger population of quiescent stem cells with limited self-renewal capability that cycle sporadically and unpredictably (the clonal succession hypothesis).
Most data support a hierarchical organization of primitive hematopoietic stem cells (HSC) on the basis of quiescence. According to these studies, primitive hematopoietic cells in G0 phase of the cell cycle exhibit the highest stem cell activity (Morrison and Weissman, 1994) . Two lines of in vitro evidence support this. Bone marrow cells resistant to cycling in response to c-kit and IL-3 and surviving 5-¯uorouracil (5FU)-challenge are highly enriched for pluripotent cells capable of generating hematopoietic colonies for prolonged periods of time (long-term culture-initiating cells, or LTC-IC) (Berardi et al., 1995) . Moreover, it has been demonstrated that the LTC-IC activity of primitive cells is highest in G0 phase, and that cells which have cycled and re-entered G0 phase progressively lose their pluripotentiality, with little residual activity after three cyclings (Gothot et al., 1997 (Gothot et al., , 1998a .
The cell cycle phenotype of primitive cells capable of reconstituting hematopoiesis in mice is controversial, however (Srour, 2000) . It has been reported that hematopoiesis can optimally be reconstituted by cells in G0 phase (Gothot et al., 1998b) , in either G0 or G1 phase (Wilpshaar et al., 2000) , or by cells which have undergone replication and subsequently entered G1 (but not G0) phase (Glimm and Eaves, 1999) . Cells in S/G2/ or M phase have minimal engraftment potential (Glimm et al., 2000) . Conceivably, there may be a cell cycle-dependence for homing to the bone marrow.
Hematopoietic stem cells (HSC) are functionally de®ned by the ability to generate long-term hematopoiesis upon transplantation. Alternatively, HSC-enriched blood subsets often are de®ned on an immunohistochemical basis in terms of positivity for CD34+ (human) or Sca-1 (murine) antigen expression. More primitive subsets selected for the absence of lineage markers (CD387 or lin7) are further enriched for Figure 1 Cell cycle control mechanisms. Selected pathways pertinent to cell cycle control in hematopoiesis are highlighted. Inhibition by cdki's prevents cyclin-cdk phosphorylation and dissociation of repressive Rb-E2F complexes reconstitution potential and reside to a higher degree in the G0 phase of the cell cycle (Leemhuis et al., 1996) . G0 cells are de®ned by 2N DNA content on Hoechst staining and by low metabolic rates (pyronin, or Py-lo, or Rhodamine, Rh-lo) . Functional selection of candidate stem cells exploits the quiescence of uncommitted, primitive cells by isolating cytokine nonresponsive cells, often through the use of suicide selection techniques such as 5-¯uorouracil (5-FU) or 4-hydroperoxycyclophosphamide (4-HC) exposure.
The appreciation that signi®cant proportions of immunophenotypically-isolated stem cell candidates are in G0 phase lent support to the view that the most primitive and pure stem cell populations remained out of the cell cycle, with successive, stochastic contribution of a portion of these cells to hematopoiesis. Retroviral marking experiments (Capel et al., 1990 ) also lent support to clonal succession of stem cell activity, but have been disputed as an accurate model of steady-state hematopoiesis (Cheshier et al., 1999) .
On the other hand, long-term in vivo BrDU labeling experiments indicate that in mice (Bradford et al., 1997; Pietrzyk et al., 1985) and to a lesser degree in primates (Mahmud et al., 2001 ) hematopoietic stem cells are constantly and slowly cycling. In mice continual BrDU administration demonstrated that Ho-lo/Rho-lo primitive HSC cycle with an average turnover time of 30 days. Similar results were reported for immunophenotypically-isolated murine HSC by Cheshier et al. (1999) , who found that 99% of lineage-negative HSC with long-term self-renewing capabilities divided every 57 days, on average. Cheshier noted that 76% of these cells were in G0-phase and 24% of the cells were in cycle at any given time, and that roughly 8% of the cells asynchronously entered the cell cycle daily. Mahmud has recently reported similar experiments in baboons, and found that BrDU was incorporated in 56 ± 83% of CD34+ cells and in 10 ± 30% of the Ho-lo/Rho-lo subset of these cells at one year. These results support the existence of both long-term quiescent and very slowly cycling HSC pools in primates. HSC cycling appears to increase with age (Morrison et al., 1996) .
Although murine HSC appear to enter the cell cycle at a higher frequency than do primate HSC, similar molecular controls of quiescence may be involved in both species. The ®nding that administration of G-CSF signi®cantly increases cell cycle entry by quiescent HSC in both mice and baboon supports this premise.
Cell cycle regulators and hematopoietic stem cells
Slow cycling by HSC necessitates the presence of appropriate cell cycle machinery to eect passage into and through G1 phase. Cheshier et al. (1999) demonstrated that individual lineage-negative HSC cells express message for cyclins D2 and D3 (but not D1). (It is interesting that G-CSF, which downmodulates cyclins D2 and D3 in dierentiating cells, appears to augment cyclin D-mediated cell cycle progression in HSC). If the cyclin D proteins are produced, a natural question is why the cells are primarily in G0 phase and enter the cycle so slowly. One can envision that stochastic progression into the cell cycle depends on a matrix of expression levels of diverse cell cycle regulators. In this view, progression into the cell cycle depends on permissible combinations of cell cycle activators and inhibitors aorded by the (random or induced)¯uctuation of individual protein levels and activities (Gonze and Goldbeter, 2001; Romond et al., 1999) .
p21WAF1 and HSC's
The cdki's are natural candidates for proteins that oppose the cell cycle progression of HSC's. The cdki p21WAF1 has been implicated as playing a predominant role in maintaining hematopoietic stem cell quiescence both in mouse and humans. In subsets of umbilical cord-derived blood cells enriched for HSC, the expression of p21 increases concurrently with cellular quiescence and HSC phenotype. For instance, although human CD34+ cells are in G0/G1 phase, almost all are negative for p21WAF1 protein expression. In contrast, p21WAF1 is expressed in a minority of CD34+lin7 cells and is uniformly expressed in the 1% of lin7 cells that are cytokine-nonresponsive and 5FU-resistant (Steinman et al., 1997) . Cheng et al. (2000b) have established a functional signi®cance for this expression pattern. They demonstrated an increase in stem cell cycling in p21 knockout mice, accompanied by an increased susceptibility of the stem cell compartment to 5-FU-induced cell death and to rapid stem cell exhaustion upon serial transplantation. p21WAF1 therefore appears to be required for stem cell quiescence. This most likely re¯ects the ability of p21 to disrupt cdk2 from p130-E2F4 complexes (Shiyanov et al., 1996) , thereby maintaining stable p130-E2F-4 association. The p130-E2F4 complex characterizes quiescent T cells (Vairo et al., 1995) and may be essential for HSC quiescence (Mayol et al., 1996) .
The high level of p21 expression in stem cells could result in part from autologous production of TGF-b1 (Eaves et al., 1991; Hatzfeld et al., 1991) . In CD34+lin7 cells, TGF ± b1 is antiproliferative (Dao et al., 1998; Fortunel et al., 2000a,b) and anti-TGF-b1 antibody has been shown to increase the recruitment of cells into cycle. TGF-b1 has been shown to increase p21 transcription in CD34+ cells (Ducos et al., 2000) and in nonhematopoietic cells (Datto et al., 1995) . However, neutralization of TGF-b1 alone has not been sucient to promote cycling of CD34+ cells selected with 4-HC or 5-FU for cytokine resistance (Steinman, unpublished observations, and Dao et al., (1998) ). This indicates that other factors are likely to sustain p21 levels in these quiescent cells. Several of the transcription factors present in primitive hematopoietic cells have been shown to be capable of upregulating p21, including wilms tumor protein (wt) (Ellisen et al., 2001; Englert et al., 1997) , MLL (Caslini et al., 2000; Phillips et al., 2000) and Rb (Decesse et al., 2001; Gartel et al., 1998; Hatzfeld et al., 1991) . A role for these factors in preventing HSC cycling has not yet been established. It is not yet known whether transcription factors which have been demonstrated to sustain HSC quiescence, such as eed (Lessard et al., 1999) or c-fos (Okada et al., 1999) exert their antiproliferative eects through p21.
Presumably the p21WAF1 checkpoint is overcome by cytokines in responsive HSC, and by transcription factors such as notch and hoxB4 which sustain the pluripotentiality of HSC while promoting cell cycling (Karanu et al., 2001; Phillips et al., 2000; Thorsteinsdottir et al., 1999; Varnum-Finney et al., 2000) . The notch pathway has been shown to upregulate p21 in the setting of growth arrest (Rangarajan et al., 2001; Sriuranpong et al., 2001) . Conceivably, notch proteins could suppress p21 in other settings.
In addition to supporting HSC quiescence, p21 may help to maintain the integrity of the stem cell pool. In such cells, which may remain quiescent for prolonged periods, genomic integrity may require active, ongoing DNA repair. p21 interferes with DNA replication but does not interfere with DNA repair (Li et al., 1994) . In fact, investigations have disclosed a repair defect in cells in which p21 has been inactivated by homologous recombination (McDonald et al., 1996) . Moreover, p21 expression protects cells from apoptosis (Asada et al., 1999; Steinman and Johnson, 2000; Suzuki et al., 1999) . p21-mediated growth arrest may then enable repair to proceed, simultaneously preventing cells from entering cell cycle stages vulnerable to apoptosis.
Other cell cycle regulators in HSC's
At this point, functional information on other cell cycle regulators and their role in HSC's is scant. p27 protein is expressed in cytokine-nonresponsive, lineage-negative HSC's (Steinman, unpublished observation). Dao et al. (1998) has reported that antisense p27 in combination with TGF-b1 neutralizing antibody (which downmodulates p15) increased the retroviral transfection eciency of CD34+lin-cells. The transduced cells were capable of repopulating immune-de®cient mice. However, suppression of p27 alone is incapable of promoting HSC cycling (Cheng et al., 2000a; Dao et al., 1998) . It is likely that either p21 or p130 (Coats et al., 1999) compensates for p27 loss and maintains these cells out of cycle. In contrast, p27 appears to provide the checkpoint on cell cycle progression in progenitor cells, where p21 expression is low (see below).
Cell cycle regulators and progenitor cells
Once HSC cycle, they give rise to early progenitor cells which proliferate extensively in response to chemokines and cytokines such as G-CSF, thrombopoietin,¯t-3 ligand, and interleukin-3. In numerous cell line models, cytokines have been shown to alter the levels and activities of speci®c cell cycle regulators, including cyclins and cdk-inhibitors. In recent years, data from knockout animals and from experiments on normal progenitor cells have expanded these ®ndings.
p27 provides a checkpoint on progenitor cell expansion
Early progenitor cells, including CFU-GEMM and those capable of generating both lymphoid and myeloid-lineage cells are present in the CD34+ compartment. Upon isolation from the bone marrow or umbilical cord, CD34+ cells are in the G0/G1 phase of the cell cycle as assessed by DNA content analysis. In these cells, expression of the cdki p27 was found to be high, while that of p21 was low (Steinman et al., 1998) . This raised the prospect that p27 contributed to growth arrest of these cells.
The ®rst suggestion that p27 could act as a nonredundant checkpoint in hematopoiesis came from p27 knockout. These mice exhibited increased hematopoietic progenitor cell activity in multiple lineages, most dramatically in CFU-GM mice (de Koning et al., 2000; Fero et al., 1996) . While the numbers and proportions of most peripheral blood cells were normal, T lymphocyte numbers were increased, concurrent with thymic and splenic hyperplasia. p27 was therefore thought likely to control cell division at the progenitor cell level and to have an ongoing antiproliferative role during T lymphocyte development.
It is possible that increased colony formation by progenitor cells in p27 knockout mice could have resulted from a p27 checkpoint either at the stem cell or progenitor cell level. In elegant studies of p27 knockout mice, Cheng et al. (2000a) demonstrated that p27 restrained progenitor cell replication but did not regulate stem cell pool size. The p27-de®cient mice exhibited normal stem cell numbers as measured by cobblestone area-forming cell (CAFC) assays, LTC-IC measurements and serial bone marrow transplantation. However, the progenitor cell pool cycled more actively in these mice, as determined by colony formation by progenitor cells and 5-FU susceptibility of progenitor cells. In competitive repopulation assays in which mice were transplanted with equal numbers of p27+/+ and p277/7 cells, the p277/7 progenitor cells outgrew those from the wild-type donor. Dijkers et al. (2000) have reported decreased survival of p277/7 early progenitor cells under cytokine deprivation in comparison with wild-type mouse marrow. This suggests that p27 may be limiting progenitor pool size in part by facilitating apoptosis.
Numerous in vitro studies of CD34+ cells and of hematopoietic cell lines have demonstrated p27 downmodulation by cytokines. This appears to be necessary in order to overcome the p27 checkpoint on progenitor cell cycling ± forced expression of p27 undermines the mitogenic response to cytokines (Hoshikawa et al., 1998) . Downmodulation of p27 may be integral to the heightened responsiveness of progenitor cells to multiple cytokines in combination. In the Mo7e-G cell line, a synergistic proliferative response to SCF and G-CSF is accompanied by a synergistic decrease in p27 levels (Duarte and Frank, 2000) . The presence of a p27 checkpoint means that proliferating progenitors are not normally expanding at their maximal capacity. Indeed, slowly-proliferating progenitor cells have been found to have high levels of p27 (Marone et al., 2000) . Increased progenitor replication in response to environmental stresses is apparently facilitated by cytokine suppression of p27.
The mechanism through which cytokines downmodulate p27 is not yet resolved. Cytokine induction of Stat 3 has been shown in vitro to result in transcriptional suppression of p27 (Fukada et al., 1998) , perhaps as a result of Stat 3-induced c-myc activation (Yang et al., 2001) . However, in other experimental settings, Stat 3 directly activates the p27 promoter (de Koning et al., 2000) . Cytokines may also downmodulate p27 by interfering with forkhead (FKHR-L1) protein-mediated activation of p27 transcription (Dijkers et al., 2000) . Another mechanism through which cytokines can downmodulate p27 is by triggering post-translational downregulation of p27 through proteasomal destruction (Pagano et al., 1995) . This is eected by a Skp1-Cullin-F-box protein (SCF) ubiquitin ligase complex and requires the Nedd8 conjugation pathway (Nakayama et al., 2000; Podust et al., 2000) . It is unclear whether cytokines aect the levels of any of these components. Cytokines may also decrease p27 levels in progenitor cells by decreasing Bcl-2 (Josefsen et al., 2000) . Bcl-2 upregulates p27 protein in quiescent cells through mechanisms distinct from its anti-apoptotic eects (Vairo et al., 2000) .
Hematopoietic cells also overcome p27-mediated growth arrest by sequestering p27 into cytoplasmic complexes. We have demonstrated relocalization of p27 into the cytoplasm of normal proliferating progenitor cells undergoing myeloid and lymphoid dierentiation (Yaroslavskiy et al., 1999 (Yaroslavskiy et al., , 2001 ). Sequestration of cytoplasmic p27 by cyclin D3-cdk4 complexes (Reynisdottir and Massague, 1997) could enable myeloid proliferation mediated by active nuclear cyclin-cdk2 complexes. Cytoplasmic p27 may also play a direct role in dierentiation, independent of its eect on the cell cycle. This would be consistent with the recent ®nding that p27 is required for Stat-3-mediated myeloid dierentiation (de Koning et al., 2000) .
p21WAF1 promotes progenitor cell expansion
Interestingly, although p21 appeared to serve as a nonredundant checkpoint inhibiting stem cell cycling, p21 is highly expressed in replicating hematopoietic progenitor and precursor cells (Furukawa et al., 2000; Steinman et al., 1998; Taniguchi et al., 1999; Yaroslavskiy et al., 1999) . The uncoupling of p21 from growth arrest in these cells could result from p21 sequestration away from cdk2 or binding of additional proteins which sustain the activity of p21-cdk complexes (Cheng et al., 1999; Estanyol et al., 1999) . Mantel et al. (1996) reported decreased colony formation in p217/7 mice, indicating that progenitor cell replication or survival required p21. Exogenous p21 could rescue colony formation by marrow from p21-de®cient mice and even augment colony formation in wild-type murine marrow (Braun et al., 1998) . This bicameral role for p21, in which it restricts primitive cell cycling but promotes expansion of the progenitor cell pool may re¯ect its ability to serve as an assembly factor for cyclin-cdk complexes without inhibiting their activity (Cheng et al., 1999; LaBaer et al., 1997) . This view is compatible with the positive eect of p21 transduction on myeloid colony formation by normal marrow. On the other hand, p21 may not augment proliferation, but simply oppose apoptosis and promote dierentiation of progenitor cells. The net eect of knocking out p21 on the peripheral blood count may re¯ect a balance between increased stem cell cycling and decreased progenitor survival.
The factors modulating p21 expression during hematopoiesis are under investigation. Repressors of p21 such as AML1 (Lutterbach et al., 2000) may be important in cell cycle control during hematopoiesis. In CD34+ cells which do not express p21, a repressive complex has been noted to bind to a p53-like recognition site in the p21 promoter. This complex disengages in the presence of cytokines promoting myeloid dierentiation, concurrent with transcriptional upregulation of p21 (Steinman et al., 1998) . In addition, forced transcriptional repression of p21 by g®-1B has been shown to suppress myelopoiesis in an in vitro model (Tong et al., 1998) . Activators of p21 are also likely to be physiologically relevant. Potential transcriptional activators of p21 in stimulated progenitor cells include hox A10 and E2F1 (Bromleigh and Freedman, 2000; Gartel et al., 1998) . At later stages of dierentiation, Stat proteins and C/EBPalpha are candidate activators of p21 expression (Bellido et al., 1998; Matsumura et al., 1997; Timchenko et al., 1996) Other cell cycle regulators in expanding progenitor cells Hematopoietic progenitor cell expansion is not simply determined by alteration in the levels of p27 and p21 by cytokines. Levels of other cell cycle regulators are actively modulated, including cdc25A (Reid and Broxmeyer, 1999) , cyclin E and cdk2 (Dai et al., 2000) . In a myeloblast model, IL-3 was shown to support progression through mid-G1 phase by inducing expression of cdk4, cyclin D2 and cyclin D3 (Ando et al., 1993; Ando and Grin, 1995) . Several investigators have surveyed steady-state levels of cell cycle regulators in various hematopoietic subsets (Della Ragione et al., 1997; Furukawa et al., 2000; Taniguchi et al., 1999) . Della Ragione detected high levels of cdk6, cyclins D2 and D3 and of the cdki p15 in all progenitors. The study by Furukawa and coworkers was conducted strictly at the RNA level and noted complex alterations in cell cycle regulator expression within and between lineages at dierent developmental stages. Dierences in expression patterns of cell cycle regulators between lineages have also been noted in HL-60 cells undergoing granulocytic or monocytic dierentiation (Burger et al., 1994) .
Altered expression and activity of cell cycle regulators during dierentiation
In general, hematopoietic dierentiation advances concurrently with decreased proliferation terminating in a growth-arrested state. Sequential peaks of cdkinhibitors are evident (Taniguchi et al., 1999; Yaroslavskiy et al., 1999) , with decreased expression of p21 and sustained p27 expression as cells engage in terminal dierentiation. Decreases in the expression of cyclin D2 and D3 appear to be necessary for terminal myeloid dierentiation (Dai et al., 2000; Kato and Sherr, 1993) .
Involvement of p21 in differentiation
p21 expression increases during chemical dierentiation of hematopoietic cell lines and cytokine-induced dierentiation of CD34+ blast cells (Jiang et al., 1994; Steinman et al., 1994 Steinman et al., , 1998 . Induced expression of exogenous p21 induces partial dierentiation of cell lines along monocytic (Liu et al., 1996) , megakaryocytic (Matsumura et al., 1997) and myeloid lineages. Antisense suppression of p21 hampers PMA-mediated dierentiation of HL-60 cells (Freemerman et al., 1997) ; however, p21-knockout mice do not exhibit gross disruption of hematopoietic dierentiation (Deng et al., 1995) . This ®nding supports redundancy of cdki's for the p21 role in dierentiation. Indeed, p19 (Adachi et al., 1997) , p27 (Matsumura et al., 1997) and Rb-family member p130 (shown to be capable of substituting for cdki's in knockout mice (Coats et al., 1999; Mori et al., 1999) ) can initiate myeloid or megakaryocytic dierentiation upon transfection into cell lines.
When upregulation of p21 by dierentiation stimuli was ®rst noted (Jiang et al., 1994; Steinman et al., 1994) , it was felt that p21 might play a role in sustaining growth arrest by dierentiated cells. This was supported by immunohistochemical studies demonstrating high levels of p21 in post-mitotic, dierentiated tissues (Parker et al., 1995) . Subsequent studies have shown that p21 protein levels fall o just prior to terminal dierentiation in hematopoietic cells (Yaroslavskiy et al., 1999) . This raises the prospect that in these cells, as in keratinocytes (Di Cunto et al., 1998) , sustained expression of p21 antagonizes terminal dierentiation.
Several laboratories have reported studies indicating the paramount involvement of p21 in the emergence of the dierentiated state rather than in dierentiation-associated growth arrest. Casini and Pellici (1999) demonstrated that suppression of p21 inhibited retinoic-acid-induced dierentiation of promyelocytic leukemia cells but did not alter the induction of growth arrest. In an erythroid dierentiation model, Hsieh et al. (2000) demonstrated p21 upregulation following erythropoietin addition, but showed that growth arrest involved p27 rather than p21. Consistent with this, in dierentiating megakaryocytes, p27 but not p21 expression is inversely related to expression of the proliferative marker Ki-67 (Taniguchi et al., 1999) .
Although p21 appears primarily to facilitate the transition to the dierentiated state rather than cell cycle withdrawal (Zezula et al., 2001) , it also inhibits proliferation in certain dierentiated cell types. Detailed study of p21 knockout mice demonstrated increased proliferation of T cells upon prolonged stimulation (Balomenos et al., 2000) . Why p21 is required to limit T cell proliferation is unknown.
How does p21 promote dierentiation? In the myeloid lineage, this may be related to direct protein ± protein interactions of p21 with C/EBPalpha (Harris et al., 2001 ) and with Stat 3 (Coqueret and Gascan, 2000) , both of which are required for granulocytic dierentiation (McLemore et al., 2001; Wang et al., 1999) . p21 also binds to the p300 transcriptional adapter and alters its activity (Coqueret and Gascan, 2000; Snowden et al., 2000) ; in addition, p21 binds directly to E2F and downmodulates E2F-1 dependent transcription (Delavaine and La Thangue, 1999) ; Genetic analysis suggests that this could be highly pertinent to dierentiation control (Muller et al., 2001) . Hox genes are highly directive of dierentiation and may be among transcriptional targets modulated by p21-complexes . p21 has many binding partners, however, and more investigations will be needed to ascertain exactly which interactions are critical to dierentiation. It has been found that a de®ciency in p217/7 oligodendrocyte dierentiation can be complemented by cyclin D-cdk4 inhibitors (Zezula et al., 2001) , raising the prospect that cdk4 activity could be targeted by p21 to enable hematopoietic dierentiation. Inhibition of cdk4 alone is not sucient to enable dierentiation, however (Amanullah et al., 2000) . A summary view of the p21 modulation during dierentiation is depicted in Figure 2 .
Involvement of p27 in differentiation
Forced overexpression of p27, like p21, has been shown to induce megakaryocytic dierentiation (Matsumura et al., 1997) and to increase the responsiveness of HL-60 cells to chemical inducers of dierentiation (Zhou et al., 1999) . As in the case of p21, there does not appear to be a strict requirement for p27 in hematopoietic dierentiation along any lineage. However, subtle imbalances may arise in the absence of physiologic p27. For instance, de Koning et al. (2000) have demonstrated impaired G-CSF-induced dierentiation of p27-de®cient myeloid progenitor cells. Colonies derived from p27-de®cient marrow contained an increased number of progenitor cells, but a decreased percentage of neutrophils, indicating disequilibrium between progenitor generation and formation of terminally-dierentiated progeny. In contrast to this potential requirement for p27 in myelopoiesis, in other lineages p27 appears to hinder dierentiation. For instance, downmodulation of p27 is a prerequisite for normal development of T cells (Tsukiyama et al., 2001) .
It should be noted that p21 and p27 do not simply substitute for each other to facilitate hematopoietic dierentiation. Because p21/p27 double knockout mice are viable, additional cell cycle regulators must be able to assume the functions of these cdki's in coordinating cell cycle changes concurrent with dierentiation.
Cell cycle regulators and erythropoiesis
A number of elegant studies have examined the functional interactions of cell cycle regulators in models of erythroid dierentiation (Dai et al., 2000; Hsieh et al., 2000; Matushansky et al., 2000a,b; Tamir et al., 2000) . These are elaborated below and in Figure  3 to illustrate the activities of cell cycle proteins in a representative lineage. Matushansky et al. (2000a,b) studied hexamethylene bisacetimide (HMBA)-induced dierentiation of murine erythroleukemia (MEL) cells (incorporated in Figure 3a ). Over the course of 5 days the cells underwent hemoglobinization and terminal growth arrest. Important changes in cell cycle regulators included a rapid, early fallo in cdk6 levels and activity, a switch of p27 from binding cdk4 to binding cdk2 at late stages, and a coordinated increase in the cdki's p15, p18, p21 and p27 starting at 3 days, with a concurrent fall o in the kinase activity of cdk2 and cdk4. The study by Hsieh et al. (2000) measured cell cycle regulators in nontransformed murine proerythroblasts undergoing in vitro dierentiation in response to erythropoietin. The ®ndings of this study were largely consistent with those of Matushansky et al. (2000b) , as were changes observed in a myeloid dierentiation model (Shimizu et al., 2000) . In contrast, Tamir noted a dierent pattern of interactions in the HB60-5 cell line, which grows in SCF plus erythropoietin and dierentiates upon removal of SCF (Figure 3b ). These cells manifested sequential peaks in cdki expression and complex formation, with p21 decreasing slightly during dierentiation and only p27 levels rising concurrent with cell cycle exit. Cdk6 levels and complex formation persisted in these cells, although the activity of this kinase, as of cdks -2 and -4 declined upon terminal dierentiation. In all of these studies p27 played a prominent role in growth arrest. Growth arrest, but not dierentiation could by recapitulated by transfection of exogenous p27 (Tamir et al., 2000) .
cdki cascades and dierentiation
Sequential peaks of cdki expression have been noted during hematopoietic, adipogenic myogenic and intestinal cell dierentiation (Franklin and Xiong, 1996; Phelps and Xiong, 1998; Tian and Quaroni, 1999b) . Evidence is mounting that the sequence of these peaks may be important in programming dierentiation during hematopoiesis. Two studies have indicated that a peak in p21 expression occuring within hours of a Figure 2 Changes in steady-state levels of p21 during myelopoiesis. Cell types and stages of dierentiation are listed. Potential binding partners of p21 are proposed to dier at dierent stages, and include interactions postulated to mediate cell cycle inhibition (cyclin-cdk's, PCNA, E2F, TOK-1), apoptosis-inhibition (ASK, SAPK, procaspase-3, gadd45, myd118), proliferation (set, TK-1, cyclin-cdk4), subcellular localization (calmodulin, ciz-1), gene expression (E2F, CKII, p300) and dierentiation (C/EBPalpha, Stat3, p300, E2F) dierentiation stimulus is necessary for dierentiation commitment but not for growth arrest, whereas a later peak in p21 is associated with growth arrest (Casini and Pelicci, 1999; Matushansky et al., 2000b; Meiyanto et al., 2001) .
In a provocative study in erythroleukemia cells, Matushansky et al. (2000b) demonstrated that transient exposure to a cdk2 inhibitor (either p21 or roscovitine) followed by arti®cial p16 induction led to terminal dierentiation. Apoptosis resulted if the order of induction was reversed. Based on analyses of cdk activities in this study, it was proposed that transient inhibition of cdk2 followed by cdk6 (but not cdk4) inhibition was crucial to erythroid dierentiation.
Uncoupling of dierentiation and growth arrest
Because dierentiation of nonlymphoid hematopoietic lineages is ultimately coupled to permanent exit from the mitotic pool, one might ask whether growth arrest alone is necessary or sucient for dierentiation. A number of studies utilizing antiproliferative agents have demonstrated that growth arrest of precursor cells is insucient to induce dierentiation (Kiyokawa et al., 1993; Yen and Forbes, 1990) .
The additional question of whether growth arrest is necessary for dierentiation is more complex. Matushansky et al. (2000b) . discovered that only cells which were in G0/G1 phase in response to cdki manipulation went on to dierentiate as a result of that manipulation. The apparent restriction of cdki-induced dierentiation to growth-arrested cells suggests that even if pro-dierentiative and anti-proliferative activities of cdki's map to distinct domains within the protein, both functions are essential for successful dierentiation (Matushansky et al., 2000b) . Such conclusions are consistent with the precept that ongoing proliferation prevents dierentiation. However, another study by the same group demonstrates that phenotypic terminal dierentiation can proceed in the presence of enforced proliferation. When erythroleukemic cells were cotransfected with cdk2 and (dominant active) cdk4 expression plasmids in the presence of a dierentiation-inducer, the cells underwent hemoglobinization without exiting the cell cycle (Matushansky et al., 2000a) . Uncoupling of dierentiation and growth arrest has been reported in other systems (Chen and Lee, 1999; Tian and Quaroni, 1999a) . Alterations reported during dierentiation of mouse erythroleukemic cells with hexamethylene bisacetimide (HMBA). D2, D3, E and A represent corresponding cyclins; K2, K4, and K6 represent cdks. The ®gure is derived from data reported by Matushansky et al. (2000a,b) and Hsieh et al. (2000) . (b) Alterations reported during dierentiation of HB60-5 cells cultured in SCF/Epo following SCF withdrawal. The labels are as described for a. Cyclin-dependent kinase activity associated with cyclins A and E is assumed to result from cdk2 (shown in parenthesis as (K2)). Figure is derived from data of Tamir et al. (2000) A number of studies have demonstrated that terminally dierentiated cells retain proliferative potential which can be induced by targeting of Rb-family members through viral genes (Crescenzi et al., 1995) or knockout strategies (Schneider et al., 1994) . It is likely that a prominent function of cell cycle regulators in terminally-dierentiated cells (as in quiescent stem cells) is to maintain the activity of repressive Rbcomplexes.
Cell cycle regulators and hematopoiesis
One can view the hematopoietic system from a range of metaphorical perspectives, all of which merely hint at its intricacy and dynamism. It is a salad of distinct cells, layered into a richly textured topography within the marrow. It is a frantic dance of erythrocytes squeezing into the bloodstream leaving their nuclei behind, of ribbons of platelets streaming out of lumbering megakaryocytes, of phagocytes tugged forward by their ruing membranes in a hungercrazed can-can. And the hematopoietic system is a volcano of production, spewing billions of new cells each hour. A fraction of a per cent change in the level of apoptosis or proliferation relative to dierentiation can lead over time to substantial aberration in the number of blood elements, as in neutropenia or leukoproliferative disorders including leukemia.
The role of cell cycle regulators within this coordinated network of communication, movement, growth and death is coming into sharper focus. They do not simply crank the proliferative machinery. Cell cycle regulators such as cdki's may exert positive or negative eects on proliferation, apoptosis, movement (Nagahara et al., 1998) and dierentiation. The levels of expression of these proteins and their choice of binding partners is stage-speci®c. Ordered sequences of cdk activity appear to be necessary not only to proceed through cell cycle checkpoints, but to pass through dierentiation stages. The multifunctional nature of these proteins enables them to function as communication junctions (Jordan et al., 2000) , with the potential to coordinate cell cycling patterns with dierentiation or to couple quiescence and survival.
